ESR1 and breast carcinoma: However, because it interacts particularly with estrogen receptors, tamoxifen may have an effect on symptoms due to hypoestrogenism, such as vaginal atrophy and dyspareunia, which are common in postmenopausal women with breast cancer 7, 8, 9, 10, 11.